Fibroblast Activation Protein α–Directed Imaging and Therapy of Solitary Fibrous Tumor
Rainer Hamacher(Technical University of Munich), Wolfgang P. Fendler(Essen University Hospital), Ken Herrmann(Klinikum rechts der Isar), Christoph E. Heilig(German Cancer Research Center), Benedikt M. Schaarschmidt(Essen University Hospital), Karina Kostbade(German Cancer Research Center), Pedro Fragoso Costa(Essen University Hospital), Sebastian Bauer(University of Duisburg-Essen), Sven‐Thorsten Liffers(German Cancer Research Center), Martin Schüler(Essen University Hospital), Sabrina Borchert(Essen University Hospital), Hans‐Ulrich Schildhaus(University of Cologne), Lale Umutlu(Essen University Hospital), Kim M. Pabst(Klinik und Poliklinik für Nuklearmedizin), Phyllis F. Cheung(German Cancer Research Center), Lukas Kessler(German Cancer Research Center), Hanno Glimm(German Cancer Research Center), Fadi Zarrad(Essen University Hospital), Johanna Falkenhorst(Essen University Hospital), Jens T. Siveke(German Cancer Research Center), Margret Droste(German Cancer Research Center), Jennifer Hüllein(Heidelberg University), Merve Akbulut(Essen University Hospital), Ilektra A. Mavroeidi(Essen University Hospital), Daniel Hübschmann(German Cancer Research Center), Monika A. Miera(Essen University Hospital), Stefan Fröhling(German Cancer Research Center)
Cited by 26
Related Papers
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations
|Journal of Clinical Oncology|2013|3.2k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations
|New England Journal of Medicine|2015|1.7k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k